Trans-RosaLEE Study: a Biomarker-directed, Translational Study
Trans-RosaLEE Study: a Biomarker-directed, Translational Study
Active, not recruiting · NCT05529862 · Registry updated 2026-01-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Trans-RosaLEE Study: a Biomarker-directed, Translational Study | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Not applicable | 2026-01-22 | NCT05529862 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut Paoli-Calmettes | 60 |
| Novartis Pharmaceuticals | 432 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Institut Paoli Calmettes | Marseille | France | 49 |